ArticleScientific reports2025
PRELP functions via multiple interactions with intrinsically weak affinity relying on ECM anchoring and remodeling.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrated analysis of scRNA-seq and bulk RNA-seq identifies matrisome-related biomarkers for prognostic stratification and immune landscape in lung adenocarcinoma.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2026Article
- Structure and Function of Ocular Proteoglycans: Essential Proteins for Vision.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
A small leucine-rich repeat proteoglycan PRELP is responsible for various biological functions. Here, to quantitatively assess the ligand binding of PRELP and its relevance to physiological activities, we validated the premise that PRELP multi-specifically binds to TGFβ1, IGFI-R, and p75NTR with relatively weak, micromolar range of affinities using surface plasmon resonance analysis. Results of a direct binding assay using N-terminal-truncated PRELP and chimeric PRELP and a dual injection assay to evaluate the binding regions and competitiveness suggested that PRELP interacts with the ligands via different but partially overlapping regions in the leucine-rich repeat domain. RNA-seq analysis revealed that PRELP greatly promotes gene expression of various extracellular matrix (ECM) components in A549 lung carcinoma cells, also at micromolar concentration. Since we reasoned that ECM anchoring contributes to an increase of apparent local concentrations of PRELP required for the weak affinity interactions, we validated the direct binding and co-localization of PRELP with ECM proteins using ELISA analysis and immunofluorescence staining. Results of this study suggest that PRELP modulates multiple interactions with intrinsically weak binding affinities through the anchoring to ECM proteins and also promotes the ECM protein expression to maintain the preferred environment to exert the molecular functions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.